Vice President Finance
CurrentOndine Biomedical is a London Stock Exchange pharma & medical device company developing photodisinfection therapies to address drug-resistant infections. { LSE - OBI }Capital Markets• Co-led the finance team during IPO on London Stock Exchange (AIM), raising $30mn USD • Collaborated with CEO on subsequent finance raises of $19mn USD. Pitched to investors, guided investment bankers, prepared investment presentation decks, provide Board upates, project managed legal workflows• Led sell-side analyst and banker relationships. Provided quarterly financial and operational updates and financial guidance• Established financial metrics framework for earnings releaseCorporate Governance • Owned the compliance function, working with London Stock Exchange regulations. Established a compliance framework and corresponding internal controls, public company policies. Served as primary contact with market regulators and nominated advisors• Served as Corporate Secretary. Planned and facilitated meetings of the Board and 3 Committee alongside the CEO • Owner of enterprise risk management process. Collaborated with department VPs to establish a corporate risk register then integrated into the corporate goal setting and budgeting processes Corporate Finance and FP&A • Established new FP&A department. Created all underlying processes and frameworks including annual budgeting process ($15mn OPEX), monthly financial reporting, business KPIs, quarterly Board reporting, treasury and liquidity management• Developed corporate model (5 year outlook) with corresponding input model (revenue, headcount, opex, etc.). • Led implementation of Salesforce CRM Accounting and Tax • Oversaw IFRS financial statement preparation, financial audit and tax reporting